A compound with the SMILES Cc1nnc(N2CCCC(C(=O)NCc3ccc(OC(C)C)cc3)C2)c2nn(-c3ccccc3)c(C)c12 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -9.055%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1nnc(N2CCCC(C(=O)NCc3ccc(OC(C)C)cc3)C2)c2nn(-c3ccccc3)c(C)c12
Cc1nnc(N2CCCC(C(=O)NCc3ccc(OC(C)C)cc3)C2)c2nn(-c3ccccc3)c(C)c12
1-(3,4-dimethyl-2-phenylpyrazolo[3,4-d]pyridazin-7-yl)-N-[(4-propan-2-yloxyphenyl)methyl]piperidine-3-carboxamide